Red blood cells (RBCs) and RBC membrane-derived nanoparticles have been historically
developed as bioinspired drug delivery systems to combat the issues of premature …

Cancer immunotherapy can effectively inhibit cancer progression by activating the
autoimmune system, with low toxicity and high effectiveness. Some of cancer …

Immunotherapy strategies that use cell‐based delivery systems have sparked much interest
in the treatment of malignancies, owing to their high biocompatibility, excellent tumor …

Cell-based therapy holds great potential to address unmet medical needs and revolutionize
the healthcare industry, as demonstrated by several therapeutics such as CAR-T cell …

Targeted therapy approaches have become the core of modern translational science and as
an intriguing field, it is the solution of the conventional drug delivery problems that were …

Cells have emerged as a promising new form of drug delivery carriers owing to their
distinguished advantages such as naturally bypassing immune recognition, intrinsic …

Erythrocytes or red blood cells (RBCs) represent a promising cell-mediated drug delivery
platform due to their inherent biocompatibility. Here, we developed an antigen delivery …

Ferroptosis is a novel form of programmed cell death impelled by iron-dependent lipid
peroxidation, which may be a potential strategy for cancer therapy. Here we demonstrated …

Bacteria-propelled biohybrid microswimmers have recently shown to be able to actively
transport and deliver cargos encapsulated into their synthetic constructs to specific regions …

Effective drug delivery in the central nervous system (CNS) needs to have long blood-
circulation half-lives, to pass through the blood–brain barrier (BBB), and subsequently to be …